Microwave zaps prostate cancer while preserving normal function

NCT ID NCT06430749

Ongoing Disease control Sponsor: Osamu Ukimura Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This trial tests a minimally invasive treatment that uses microwaves to destroy only the cancerous part of the prostate, leaving healthy tissue intact. The goal is to control the cancer while avoiding common side effects of full prostate removal, such as urine leakage and erectile problems. The study includes 65 men with localized prostate cancer and will check if the cancer disappears on scans and biopsies.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: microwave tissue coagulation (device)
What this could lead to: If successful, this could offer a less invasive option for prostate cancer that controls the disease while reducing side effects like urinary leakage and sexual dysfunction.
What could go wrong: This is an early-stage trial with only 65 participants, so results may not apply to all patients. The treatment may not fully eliminate cancer or could miss some cancer cells.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CLINICALLY LOCALIZED PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prostate cancer prostate carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CANCER

Contacts and locations

Locations

Kyoto Prefectural University of Medicine

Kyoto, Kyoto, 602-8566, Japan

More trials for these conditions

Other studies related to the condition(s) this trial covers.